News
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics ...
Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...
Lynlee Brown discusses the decisions that companies must make to adjust to the tariffs while also ensuring the ongoing innovation continues.
Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial Success ...
Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial Success ...
Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial Success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback